UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004349
Receipt number R000004710
Scientific Title PhaseI/II study of Docetaxel/S-1 with radiation for unresectable and/or recurrent esophageal cancer
Date of disclosure of the study information 2010/11/01
Last modified on 2013/10/23 12:22:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

PhaseI/II study of Docetaxel/S-1 with radiation for unresectable and/or recurrent esophageal cancer

Acronym

SP vs DS

Scientific Title

PhaseI/II study of Docetaxel/S-1 with radiation for unresectable and/or recurrent esophageal cancer

Scientific Title:Acronym

SP vs DS

Region

Japan


Condition

Condition

unresectyable esophageal cancer,
recurrent esophageal cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To clarify the efficacy and the safety of this regimen for unresectable esophageal cancer patient without distant metastasis and recurrent esophageal cancer patient, using the dosage determined by previous phase I study.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

overall response

Key secondary outcomes

Overall suevivalsurvival
Time to progression
toxicity
Local conterol rate


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Patients were given S-1 (60mg/m2/day) orally from days 1 to 14, and Docetaxel (20 mg/m2 ) intravenously on days 1 and 8. Patients received radiation in 2.0 Gy daily fractions from days 1 to 21, for a total of 30 Gy. Patients were given a seven-day rest after the first course, and then treated with the same regimen from days 28 to 49.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

1.The patients must have histologically proven squamous cell carcinoma of the esophagus.
2.The tumor is T4 and/or M1 LYM without other organ metastasis or recurrent cancer.
3.The tumor has a measurable lesion for evaluation.
4.No previous treatment or more 4 weeks passed before previous treatment
5.All areas of the disease can be encompassed in the radiation port.
6.The patient's performance status is 0 to 1.
7.The patient's age is 18- 80 years.
8. Adequate organ function
9.WBC count is 4,000/mm3 or more and neutrophil count is 2000 /mm3 or more
Platelet count is 100,000/mm3 or more
Hemoglobin is 9.5 g/dl or more
AST and ALT levels are within twice the normal upper limits
Serum bilirubin level is 1.5 mg/dl or less
Serum creatinin levels are 1.5 mg/dl or less
10.Life expectancy expectd more than 12 weeks
11. Written informed consent

Key exclusion criteria

Excluded criteria is follow;
1.the case complicated severe heart failure,liver chirrhosis, uncontrolled diabets, interstitial pneumonia or fibriod lung, pooling of pleural effusion needed treatment and pericardial effusion.
2.the case suspected of infection with feaveer
3.the case had the motion disturbance, peripheral nerve palsy and severe edema
4.the case complicated other active cancer
5.pregnant woman or lactational woman

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshihiro Hirai

Organization

Kawasaki Medical University

Division name

Department of Digestive Surgery

Zip code


Address

Matsushima 577, Kurashi City, Okayama

TEL

086-462-1111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Hideo Matsumoto

Organization

Kawasaki Medical University

Division name

Department of Digestive Surgery

Zip code


Address

Matsushima 577, Kurashi City, Okayama

TEL

086-462-1111

Homepage URL


Email

h-mastu@med.kawasaki-m.ac.jp


Sponsor or person

Institute

Department of Digestive surgery,
Kawasaki Medical University

Institute

Department

Personal name



Funding Source

Organization

not existed

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

川崎医科大学附属病院


Other administrative information

Date of disclosure of the study information

2010 Year 11 Month 01 Day


Related information

URL releasing protocol


Publication of results

Partially published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2006 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2010 Year 12 Month 01 Day

Last follow-up date

2013 Year 12 Month 01 Day

Date of closure to data entry

2013 Year 12 Month 01 Day

Date trial data considered complete

2013 Year 12 Month 01 Day

Date analysis concluded

2015 Year 12 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 10 Month 07 Day

Last modified on

2013 Year 10 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004710


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name